Dendritic cell maturation and activation

Dendritic cell maturation and activation describes a coordinated biological process, not a single molecule or receptor; it refers to the functional transformation of dendritic cells (DCs) from an immature to a mature state, enabling efficient activation of T cells and initiation of adaptive immune responses. It is not a molecular target or receptor by itself, but a critical event regulated by multiple molecules, receptors, and signaling pathways. Dendritic cell maturation and activation is the essential process through which dendritic cells (APCs) transition from an immature, antigen-capturing state to a mature, antigen-presenting state after sensing pathogens or danger signals. This process is regulated by the recognition of PAMPs and DAMPs via pattern recognition receptors such as TLRs, leading to upregulation of MHC and costimulatory molecules, induction of pro-inflammatory cytokine production, metabolic reprogramming, and migration to lymphoid organs for T cell priming. Mature DCs are central to inducing adaptive immune responses and are a focus of immunotherapy, vaccine development, and studies of immune tolerance and cancer immunity. While this process is therapeutically modulated, it is not a specific molecular target but comprises multiple steps and molecular components. Summary: - "Dendritic cell maturation and activation" is a functional immunological process, not a canonical receptor or molecule, and is not a valid molecular target name under standard pharmacological or biological classifications. - To structure information for therapeutic targets, refine to specific molecules (e.g., "Toll-like receptor 4," "CD40," "CCR7," etc.), each of which can be considered an individual target with their own structured data.

Other names

Dendritic cell activationDC maturation